It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Langerhans cells (LC) are thought to be the only mononuclear phagocyte population in the epidermis where they detect pathogens. Here, we show that CD11c+ dendritic cells (DCs) are also present. These cells are transcriptionally similar to dermal cDC2 but are more efficient antigen-presenting cells. Compared to LCs, epidermal CD11c+ DCs are enriched in anogenital tissues where they preferentially interact with HIV, express the higher levels of HIV entry receptor CCR5, support the higher levels of HIV uptake and replication and are more efficient at transmitting the virus to CD4 T cells. Importantly, these findings are observed using both a lab-adapted and transmitted/founder strain of HIV. We also describe a CD33low cell population, which is transcriptionally similar to LCs but does not appear to function as antigen-presenting cells or acts as HIV target cells. Our findings reveal that epidermal DCs in anogenital tissues potentially play a key role in sexual transmission of HIV.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia
2 Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
3 Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
4 Australia Plastic Surgery, Sydney, New South Wales, Australia
5 Westmead Hospital, Westmead, New South Wales, Australia
6 Royal North Shore Hospital, St Leonards, New South Wales, Australia
7 Burns Unit, Concord Repatriation General Hospital, Sydney, New South Wales, Australia
8 Dr Jake Lim PLC, Parramatta, New South Wales, Australia
9 Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia; Westmead Hospital, Westmead, New South Wales, Australia
10 AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Frederick, MD, USA
11 School of Health and Biomedical Sciences, College of Science, Engineering and Health, RMIT University, Melbourne, Victoria, Australia
12 The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
13 Emory Vaccine Center, Atlanta, GA, USA
14 Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK; Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK